Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
09/2003
09/25/2003CA2478713A1 Non-peptide gnrh antagonists
09/25/2003CA2478653A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003CA2478540A1 Indazoles substituted with an anti-cancerous activity
09/25/2003CA2478331A1 Peptide deformylase inhibitors
09/25/2003CA2459836A1 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
09/24/2003EP1347463A2 Novel electrically conductive polymer, sensor using the same, and method for detecting target molecule using the sensor
09/24/2003EP1346992A1 Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
09/24/2003EP1345943A2 Inhibitors of papilloma virus
09/24/2003EP1345932A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345931A2 Cysteine protease inhibitors
09/24/2003EP1345930A2 Pharmaceutical compounds
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345924A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345907A2 7-heterocyclyl quinoline and thieno 2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
09/24/2003EP1345905A1 Potassium channel inhibitors
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1150953B1 Indole derivatives and their use as mcp-1 receptor antagonists
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0973746B1 Substituted 3-cyano quinolines
09/24/2003EP0904270B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444563A Quinoline and quinazoline derivatives
09/24/2003CN1444481A Protease inhibitors
09/24/2003CN1444477A Thrombopoietin mimetics
09/24/2003CN1122040C Suger modified nucleosides and their use of synthesis of oligonucleotide
09/24/2003CN1121859C Process for preparing pharmaceutical composition for treatment or prevention hypertension
09/23/2003USRE38257 Piperdine derivatives and hypotensives containing the same
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624180 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/18/2003WO2003076938A1 Novel fluorescent label compounds
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076437A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076418A1 Quinazolinone modulators of nuclear receptors
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076405A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003WO2003076403A1 1,2-disubstituded-6-oxo-3-phenyl-piperidine-3-carboxamides and combinatorial libraries thereof
09/18/2003WO2003076402A1 Therapeutic agent for pain
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2003048122A3 Inhibitors of cytosolic phospholipase a2
09/18/2003WO2003040256A3 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
09/18/2003WO2003011851A3 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
09/18/2003WO2002102796A8 Stereoselective method for the preparation of nucleoside analogues
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003WO2002034745A8 Chemokine receptor binding heterocyclic compounds
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176496 Administering an antiproliferative agent in combination with a potentiating effective amount of a N- substituted dithiocarbamate ester or a pharmaceutically acceptable salt thereof
09/18/2003US20030176491 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer
09/18/2003US20030176489 Glyt-1 inhibitors
09/18/2003US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders
09/18/2003US20030176478 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease
09/18/2003US20030176464 Phenyl substituted 4-hydroxy tetrahydroxypyridone
09/18/2003US20030176461 Aminopiperidines
09/18/2003US20030176454 N-coating heterocyclic compounds
09/18/2003US20030176443 Pyridylpyrimidine derivatives as effective compounds against prion diseases
09/18/2003US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection
09/18/2003US20030176400 For therapy of allergic diseases such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, etc., systemic mastocytosis
09/18/2003US20030176392 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV")
09/18/2003US20030176319 N4-acylcytosine-1,3- dioxolane nucleosides for treatment of viral infections
09/18/2003CA2478936A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/18/2003CA2478110A1 Novel fluorescent label compounds
09/18/2003CA2423259A1 New compounds derived from quinazoline, the process for preparing them, and the pharmaceutical compositions containing them
09/17/2003EP1343780A1 Piperazine derivatives for treatment of bacterial infections
09/17/2003EP1343779A2 Novel compounds
09/17/2003EP1343778A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343765A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
09/17/2003EP1343759A1 Benzo(f) isoindol derivatives and their use as ep4 receptor ligands
09/17/2003EP1343757A1 Indole derivatives
09/17/2003EP1343756A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1343503A1 Heteroaryl urea neuropeptide y y5 receptor antagonists
09/17/2003EP1224174B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
09/17/2003EP1196411B1 Bradykinin b1 receptor antagonists
09/17/2003EP0889034B1 Aminopyridine derivatives
09/17/2003EP0668762B1 Isobutenyl-substituted taxanes and their pharmaceutical compositions
09/17/2003CN1443184A 嘧啶衍生物 Pyrimidine derivatives
09/17/2003CN1443180A Novel compounds having antiinflamatory activity process for their preparation and pharmaceutical compositions containing them
09/17/2003CN1443174A Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
09/17/2003CN1443167A Azacyclic compounds for use in treatment of 5-serotonin related diseases
09/17/2003CN1443165A Cyclopentanoindoles, compositions containing such compounds and methods of treatment
09/17/2003CN1443164A Pyrrolidine derivatives as metalloprotease inhibitors
09/17/2003CN1443163A Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
09/17/2003CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives
1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 523